Fundraising Fox
/People
Sign in

Daniel L. Vasella, M.D.

Investor

Advisor at Time BioVentures

Basel, Basel, Switzerland

Find your path to Daniel

45 people in our graph can introduce you to Daniel.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Carlo Rizzuto to introduce you to Daniel

You →Carlo · together at Novartis AG (2010) →Daniel

Ask Jamie Chen to introduce you to Daniel

You →Jamie · 11 people · together at Novartis AG →Daniel

Sign up to find every way you can get introduced to Daniel

  • Your email: the people you already email who know Daniel
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Daniel
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Daniel Vasella, M.D., is Chairman of the Board of Numab Therapeutics AG, having joined the board in 2019 and become Chairman in 2020. He previously served as Chairman of Novartis AG from 1999 to 2013 and as its CEO from 1996 to 2010, and earlier held CEO and senior development and marketing roles at Sandoz Pharma. He earned an M.D. from the University of Bern in 1980 and completed studies at Harvard Business School.

Invests in

Biotech

Experience

  1. POP DüsseldorfFaculty Membercurrent2016 — present
  2. Numab Therapeutics AGChairman Of The Board2020 — 2023Schlieren, Zurich, Switzerland
  3. NovartisChairman1999 — 2013
  4. Novartis AGCEO1996 — 2010

Skills & more

Pharmaceutical Industry55Clinical Development29Oncology13Clinical Trials9Biotechnology15Pharmaceutical Sales16Drug Development29Lifesciences8Regulatory Affairs8Drug Discovery13Sales Effectiveness12Technology Transfer7
+4 moreMarket AccessCardiologyDiabetesLife Sciences

Languages English · French · German

From Daniel's professional profile.

Investments

Board seats

American Express CompanyNumab Therapeutics AGPepsiCoSciClone Pharmaceuticals

Investor

ImmunOs TherapeuticsMpharma

Sources: the firm's website · curated public sources.

Colleagues at Time BioVentures

Bradford Cornell
Advisor at Time BioVentures
D.A. Wallach
General Partner at Time BioVentures
Jay Flatley
Advisor at Time BioVentures
Jim Allison, Ph.D.
Scientific Advisor at Time BioVentures
Leonard Schaeffer
Advisor at Time BioVentures
Pam Sharma, M.D., Ph.D.
Scientific Advisor at Time BioVentures
Paul McEwan
Scientific Advisor at Time BioVentures
Peter Attia, M.D.
Scientific Advisor at Time BioVentures

Frequently asked questions

Who is Daniel L. Vasella, M.D.?
Daniel Vasella, M.D., is Chairman of the Board of Numab Therapeutics AG, having joined the board in 2019 and become Chairman in 2020. He previously served as Chairman of Novartis AG from 1999 to 2013 and as its CEO from 1996 to 2010, and earlier held CEO and senior development and marketing roles at Sandoz Pharma. He earned an M.D. from the University of Bern in 1980 and completed studies at Harvard Business School.
Where does Daniel L. Vasella, M.D. work?
Daniel L. Vasella, M.D. is Advisor at Time BioVentures.
What does Daniel L. Vasella, M.D. invest in?
Daniel L. Vasella, M.D. invests in Biotech.
What boards does Daniel L. Vasella, M.D. sit on?
Daniel L. Vasella, M.D. holds tracked board seats at American Express Company, Numab Therapeutics AG, PepsiCo, SciClone Pharmaceuticals.
What companies has Daniel L. Vasella, M.D. invested in?
Investments tracked here include ImmunOs Therapeutics, Mpharma.
Where did Daniel L. Vasella, M.D. go to school?
Daniel L. Vasella, M.D. studied at University of Bern and University of Fribourg (Doctor of Medicine (M.D.)).

Shared employers

Also worked at Numab Therapeutics AG1

David UrechVenture Partner at BioMedPartners